Revenue: The sum of all revenue fields included for a company's operating activities.
United Therapeutics Corporation (UTHR) had Revenue of $783.30M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$783.30M |
$333.00M |
|
$99.50M |
|
$683.80M |
|
$452.50M |
|
$330.80M |
|
$41.90M |
|
$372.70M |
|
$372.70M |
|
$333.00M |
|
$333.00M |
|
$333.00M |
|
$333.00M |
|
$330.80M |
|
$355.00M |
|
42.60M |
|
45.80M |
|
$7.82 |
|
$7.27 |
|
| Balance Sheet Financials | |
$3.48B |
|
$1.93B |
|
$3.74B |
|
$7.22B |
|
$607.80M |
|
-- |
|
$212.00M |
|
$819.80M |
|
$6.40B |
|
$6.29B |
|
$6.40B |
|
42.68M |
|
| Cash Flow Statement Financials | |
$776.90M |
|
$831.20M |
|
$-1.36B |
|
$1.56B |
|
$1.80B |
|
$246.10M |
|
$77.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
87.30% |
|
42.23% |
|
42.23% |
|
-- |
|
47.58% |
|
42.51% |
|
$568.10M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.51 |
|
2.52 |
|
35.65 |
|
5.20% |
|
5.30% |
|
4.61% |
|
5.20% |
|
$149.97 |
|
$12.40 |
|
$16.96 |
|